TY - JOUR
T1 - Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction
AU - Okamoto, Yoshichika
AU - Chaves, Alysia
AU - Chen, Jingchun
AU - Kelley, Robert
AU - Jones, Keith
AU - Weed, Harrison G.
AU - Gardner, Kevin L.
AU - Gangi, Lisa
AU - Yamaguchi, Mamoru
AU - Klomkleaw, Wuthichai
AU - Nakayama, Tomohiro
AU - Hamlin, Robert L.
AU - Carnes, Cynthia
AU - Altschuld, Ruth
AU - Bauer, John
AU - Hai, Tsonwin
PY - 2001
Y1 - 2001
N2 - Activating transcription factor 3 (ATF3) is a member of the CREB/ATF family of transcription factors. Previously, we demonstrated that the expression of the ATF3 gene is induced by many stress signals. In this report, we demonstrate that expression of ATF3 is induced by cardiac ischemia coupled with reperfusion (ischemia-reperfusion) in both cultured cells and an animal model. Transgenic mice expressing ATF3 under the control of the α-myosin heavy chain promoter have atrial enlargement, and atrial and ventricular hypertrophy. Microscopic examination showed myocyte degeneration and fibrosis. Functionally, the transgenic heart has reduced contractility and aberrant conduction. Interestingly, expression of sorcin, a gene whose product inhibits the release of calcium from sarcoplasmic reticulum, is increased in these transgenic hearts. Taken together, our results indicate that expression of ATF3, a stress-inducible gene, in the heart leads to altered gene expression and impaired cardiac function.
AB - Activating transcription factor 3 (ATF3) is a member of the CREB/ATF family of transcription factors. Previously, we demonstrated that the expression of the ATF3 gene is induced by many stress signals. In this report, we demonstrate that expression of ATF3 is induced by cardiac ischemia coupled with reperfusion (ischemia-reperfusion) in both cultured cells and an animal model. Transgenic mice expressing ATF3 under the control of the α-myosin heavy chain promoter have atrial enlargement, and atrial and ventricular hypertrophy. Microscopic examination showed myocyte degeneration and fibrosis. Functionally, the transgenic heart has reduced contractility and aberrant conduction. Interestingly, expression of sorcin, a gene whose product inhibits the release of calcium from sarcoplasmic reticulum, is increased in these transgenic hearts. Taken together, our results indicate that expression of ATF3, a stress-inducible gene, in the heart leads to altered gene expression and impaired cardiac function.
UR - http://www.scopus.com/inward/record.url?scp=0034880081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034880081&partnerID=8YFLogxK
U2 - 10.1016/S0002-9440(10)61735-X
DO - 10.1016/S0002-9440(10)61735-X
M3 - Article
C2 - 11485922
AN - SCOPUS:0034880081
VL - 159
SP - 639
EP - 650
IS - 2
ER -